Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandlæge Aviaja Fleischer ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5%   Bankruptcy risk   5.6% 13.9% 11.4% 7.8% 16.5% 13.4% 12.6% 12.6%   Credit score (0-100)   42 16 20 31 10 17 19 19   Credit rating   BBB BB BB BB BB BB BB BB   Credit limit (kDKK)   -0.0 -0.0 -0.0 0.0 0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,568 1,103 2,535 6,038 4,896 6,017 0.0 0.0   EBITDA   319 -155 769 4,706 3,286 3,852 0.0 0.0   EBIT   122 -688 176 4,058 2,566 3,168 0.0 0.0   Pre-tax profit (PTP)   47.5 -800.2 16.2 901.4 -568.7 20.3 0.0 0.0   Net earnings   36.9 -631.4 18.4 702.3 -446.9 14.6 0.0 0.0   Pre-tax profit without non-rec. items   47.5 -800 16.2 901 -569 20.3 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   795 3,014 2,693 2,463 1,808 1,296 0.0 0.0   Shareholders equity total   -720 -1,351 -1,333 -631 -1,078 -1,063 -1,113 -1,113   Interest-bearing liabilities   2,130 2,614 2,629 1,417 1,123 1,262 1,162 1,162   Balance sheet total (assets)   1,547 3,942 3,548 3,335 2,587 2,696 48.8 48.8   Net Debt   2,126 2,609 2,627 1,218 1,100 1,260 1,162 1,162     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,568 1,103 2,535 6,038 4,896 6,017 0.0 0.0   Gross profit growth   7.8% -29.7% 129.9% 138.2% -18.9% 22.9% -100.0% 0.0%   Employees   3 3 6 3 4 4 0 0   Employee growth %   200.0% 0.0% 100.0% -50.0% 33.3% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,547 3,942 3,548 3,335 2,587 2,696 49 49   Balance sheet change%   -11.4% 154.8% -10.0% -6.0% -22.4% 4.2% -98.2% 0.0%   Added value   319.1 -154.6 768.6 4,706.0 3,213.7 3,852.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -385 1,621 -978 -943 -1,440 -1,261 -1,296 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   4.0 -1.0 1.0 2.0 3.0 4.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   7.8% -62.4% 7.0% 67.2% 52.4% 52.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   5.5% -18.1% 3.5% 24.9% -9.3% 6.8% 0.0% 0.0%   ROI %   5.9% -28.8% 6.8% 53.6% -27.2% 20.5% 0.0% 0.0%   ROE %   2.2% -23.0% 0.5% 20.4% -15.1% 0.6% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   -31.8% -25.5% -27.3% -15.9% -29.4% -28.3% -95.8% -95.8%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   666.3% -1,687.2% 341.8% 25.9% 33.5% 32.7% 0.0% 0.0%   Gearing %   -295.8% -193.4% -197.2% -224.6% -104.2% -118.7% -104.4% -104.4%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.8% 4.9% 6.2% 9.8% 16.9% 19.5% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   0.4 0.3 0.3 0.8 0.8 1.3 0.0 0.0   Current Ratio   0.4 0.3 0.3 0.8 0.8 1.3 0.0 0.0   Cash and cash equivalent   3.9 5.4 2.6 198.4 22.5 2.1 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -516.1 -1,432.7 -1,245.2 -181.1 -125.4 321.5 -580.9 -580.9   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   106 -52 128 1,569 803 963 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   106 -52 128 1,569 821 963 0 0   EBIT / employee   41 -229 29 1,353 641 792 0 0   Net earnings / employee   12 -210 3 234 -112 4 0 0